Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Magnusson BP"'
Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD.
Autor:
Strâmbu IR; National Institute of Pneumology 'Marius Nasta', Bucharest, Romania., Kobalava ZD; Department of Internal Medicine, RUDN University, Moscow, Russia., Magnusson BP; Novartis Pharma AG, Basel, Switzerland., MacKinnon A; Mereo BioPharma Group plc, London, UK., Parkin JM; Mereo BioPharma Group plc, London, UK.
Publikováno v:
COPD [COPD] 2019 Dec; Vol. 16 (5-6), pp. 344-353. Date of Electronic Publication: 2019 Nov 04.
Autor:
Magnusson BP; Biostatistics and Pharmacometrics, Novartis Pharma AG, Basel, Switzerland., Schmidli H; Biostatistics and Pharmacometrics, Novartis Pharma AG, Basel, Switzerland., Rouyrre N; Biostatistics and Pharmacometrics, Novartis Pharma AG, Basel, Switzerland., Scharfstein DO; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Publikováno v:
Statistics in medicine [Stat Med] 2019 Oct 15; Vol. 38 (23), pp. 4761-4771. Date of Electronic Publication: 2019 Aug 06.
Autor:
Bornkamp B; Novartis Pharma AG, Basel, CH-4002, Switzerland., Ohlssen D; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, 07936-1080, USA., Magnusson BP; Novartis Pharma AG, Basel, CH-4002, Switzerland., Schmidli H; Novartis Pharma AG, Basel, CH-4002, Switzerland.
Publikováno v:
Pharmaceutical statistics [Pharm Stat] 2017 Mar; Vol. 16 (2), pp. 133-142. Date of Electronic Publication: 2016 Dec 09.
Autor:
Magnusson BP; Novartis Pharma AG, Basel, Switzerland. baldur.magnusson@novartis.com, Turnbull BW
Publikováno v:
Statistics in medicine [Stat Med] 2013 Jul 20; Vol. 32 (16), pp. 2695-714. Date of Electronic Publication: 2013 Jan 13.